Comparison of Cardiopulmonary Effects of Medetomidine-Midazolam, Acepromazine-Butorphanol and Midazolam-Butorphanol in Dogs

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 46, Issue 6, 1999, Pages 353-359

  Kojima, K ^a   Nishimura, R ^a   Mutoh, T ^a   Takao, K ^a   Matsunaga, S ^a   Mochizuki, M ^a   Sasaki, N ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

EID: 0042285123     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.1999.00224.x     Document Type: Article

References (16)

1. Bednarski, R. M., 1992: Anesthetic Concerns for Patients with Cardiomyopathy. Vet. Clin. North. Am. Small Anim. Pract. 22, 460-465.
2. Cornick, J. L., and S. M. Hartsfield, 1992: Cardiopulmonary and behavioral effects of combinations of acepromazine/butorphanol and acepromazine /oxymorphone in dogs. J. Am. Vet. Med. Assoc. 200, 1952-1956.
3. Dyson, D. H., and M. Atilola, 1992: A clinical comparison of oxymorphone-acepromazine and butorphanol-acepromazine sedation in dogs. Vet. Surg. 21, 418-421.
4. Farver, T. B., S. C. Haskins, and J. D. Patz, 1986: Cardiopulmonary effects of acepromazine and of the subsequent administration of ketamine in the dog. Am. J. Vet. Res. 47, 631-635.
5. Gross, M. E., J. A. Smith, and W. J. Tranquilli, 1993: Cardiorespiratory effects of combined midazolam and butorphanol in isoflurane-anesthetized cats Vet. Surg. 22, 159-162.
6. Hall, L. W., and K. W. Clarke, 1991: Principles of sedation, analgesia and premedication. In: Hall, L. W., and K. W. Clarke (eds), Veterinary Anaesthesia, 9th edn, pp. 51-79. Bailliere Tindall, London.
7. Hayashi, K., R. Nishimura, A. Yamaki, H. Kim, S. Matsunaga, N. Sasaki, and A. Takeuchi, 1994: Comparison of sedative effects induced by medetomidine, medetomidine-midazolam and medetomidine-butorphanol in dogs. J. Vet. Med. Sci. 56, 951-956.
8. Hayashi, K., R. Nishimura, A. Yamaki, H. Kim, S. Matsunaga, N. Sasaki, and A. Takeuchi, 1995: Cardiopulmonary effects of medetomidine, medetomidine-midazolam and medetomidine-midazolamatipamezole in dogs. J. Vet. Med. Sci. 57, 99-104.
9. Kojima, K., R. Nishimura, T. Mutoh, K. Takao, S. Matsunaga, M. Mochizuki, and N. Sasaki, 1999: Comparison of sedative effects medetomidine-midazolam, acepromazine-butorphanol and midazolam-butorphanol in dogs. J. Vet. Med. A 46, 141-148.
10. Matsunaga, S., H. Kim, R. Nishimura, and N. Sasaki, 1997: The mechanism of hemdynamic changes by medetomidine in dogs. In: Raptopoubs, D. (ed.), Proceedings of the 6th International Congress ot Veterinary Anaesthesiology, Thessaloniki, Greece, p. 153. University of Thessaloniki, Thessaloniki.
11. Reves, J. G., R. J. Fragen, H. R. Vinik, and D. J. Greenblatt, 1985: Midazolam. Pharmacology and Uses. Anesthesiol. 62, 310-324.
12. 2-adrenergic agonists and benzodiazepines in rats. Anesthesiol. 76, 1004-1011.
13. Schmelling, W. T., J. P. Kampine, D. L. Roering, and D. C. Warltier, 1991: The effects of the stereoismers of the alpha2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in coscious dogs. Anesthesiol. 75, 499-511.
14. Stepien, R. L., J. D. Bonagura, R. M. Bednarski, and W. W. Muir, 1995: Cardiorespiratory effects of aceprornazine maleate and buprenorphine hydrochloride in clinically normal dogs. Am. J. Vet. Res. 56, 78-84.
15. Trim, C. M., 1983: Cardiopulmonary effects of butorphanol tartrate in dogs. Am. J. Vet. Res. 44, 329-331.
16. 2 anesthetized healthy dogs. Am. J. Vet. Res. 50, 1340-1342.